International Post-Stroke Epilepsy Research Repository
Part of paid clinical trials in New Haven, Connecticut.
- Sponsor
- Yale University
- Study ID
- NCT06108102
- Status
- Enrolling By Invitation
Conditions
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Presence of stroke, either ischemic or hemorrhagic (intracerebral and subarachnoid) — OTHERPresence of ischemic or hemorrhagic stroke confirmed by neuroimaging and clinical diagnosis
Study Details
The International Post-Stroke Epilepsy Research Repository (IPSERR): The study aims to collate and categorize data reported by post-stroke epilepsy (PSE) researchers and lodge it within the IPSERR. Using the IPSERR database, we will conduct two individual patient data (IPD) analyses: (1) determine epilepsy, functional, and cognitive outcomes in stroke patients who develop post-stroke seizure and (2) build and validate post-stroke epilepsy prediction model and compare performance against existing models.
Key Dates
- Start date
- Mar 1, 2024
- Status verified
- Oct 2025
- Primary completion
- Dec 31, 2029
- Completion
- Dec 31, 2029
Study Design
- Enrollment
- 8,000 participants (estimated)
Arms
- Arm: Post-stroke epilepsyStroke patients aged ≥18 years, with ischemic or hemorrhagic stroke, presenting with early or late onset post-stroke seizures.
- Arm: No post-stroke epilepsyStroke patients aged ≥18 years, with ischemic or hemorrhagic stroke, presenting with no post-stroke seizures.
Primary Outcome Measure
Mortality (modified Rankin Scale = 6) [ Time Frame: At 1 year, 2 year, and 5 year follow-up ]
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Yale University | New Haven | Connecticut | 06511 | - |
Find similar trials in New Haven, CT
By specialty
By research site
Related Studies
- Neurologic Stem Cell Treatment StudyRecruiting · MD Stem Cells · Westport, Connecticut
- GORE® CARDIOFORM Septal Occluder and Antiplatelet Medical Management for Reduction of Recurrent Stroke in Patients With Patent Foramen Ovale (PFO): the REDUCE Post Approval StudyRecruiting · W.L.Gore & Associates · Tucson, Arizona
- Anticoagulation for New-Onset Post-Operative Atrial Fibrillation After CABGPHASE3 · Recruiting · Icahn School of Medicine at Mount Sinai · Little Rock, Arkansas
- Stroke Thrombectomy and Aneurysm RegistryRecruiting · Medical University of South Carolina · Birmingham, Alabama